Blog

  1. Dr. Post’s on Animal Radio

    Since 2001, Animal Radio® has been America’s “most-listened-to” pet show. Over a 350,000 pet-lovers tune-in weekly on 125 AM-FM radio stations and XM Satellite RadioThe two-hour celebration of our pets is hosted by veteran air-talent Hal Abrams and Judy FrancisThe Animal Radio® Family includes Veterinarian Dr. Debbie, News Director Lori Brooks, Groomer Joey Villani, Animal Communicator Joy TurnerTravel Reporter Susan Sims and a cast of hundredsFrequent guest-hosts include the likes of Jenna Fischer (The Office), Glenn Close (Damages) and Cesar Millan.Through education and awareness, together we’re helping animals live healthy, happier lives. Dr. Post was featured on a series which are listed below: Animal Radio® Episode 754

    Cancer Awareness Month:
    Cancer is no longer a death sentence for dogs or cats. Amazing breakthroughs in technology allow vets to treat cancer fairly effectively. Dr. Gerald Post from The Veterinary Cancer Center is back to answer questions.

    Animal Radio® Episode 709

    Preventing Cancer :
    Dr. Gerald Post is back with basic things you can do to reduce the odds against your pet. If Cancer is detected and treated early, many of our pets have a great chance at a healthy outcome. Dr. Post has the low-down on pesticides and your pet.

    Animal Radio® Episode 696

    Cancer Odds:
    Believe it or not, some breeds of dogs are pre-disposed to getting cancer. Dr. Gerald Post, founder of the Veterinary Cancer Center, is back on the air with a list of breeds that have a better chance of getting certain cancers.

    Animal Radio® Episode 688

    Cancer, Not A Death Sentence:
    As many as 70% of our pets will get cancer. But with advances in medical technology, now we can treat our pets like we treat humans. And dogs are able to withstand chemotherapy better than humans. The founder of the Animal Cancer Foundation, Dr. Gerald Post, reminds us that information is the best weapon against this ugly disease.

    Animal Radio® Episode 674

    Number One Killer
    There are more cancer related deaths with dogs than humans. What is causing all these fatalities? Are some breeds more susceptible to cancer than other. Dr. Gerald Post from The Veterinary Cancer Center has some answers and says your groomer may be the first line of defense against cancer.

    Animal Radio ® Episode 415

    Dr. Gerald Post explores cancer in pets

  2. Consider Giving Hope This Year to a Pet in Need

    Dear fellow Animal Lover, Everyone who walks into this practice loves their pet, of that we are sure. Despite this, some pet parents do not have the resources to treat their beloved pets. The Veterinary Cancer Center has been a major supporter of a non-profit organization called the Riedel & Cody Fund. This 501(c)3 organization enables pets whose owners cannot afford cancer therapy to receive treatment. The Riedel and Cody Fund has already helped hundreds of pets and pet parents around the country. We at The Veterinary Cancer Center have partnered with the Riedel and Cody Fund to raise money for the local pets and pet owners who need our help. The people of Fairfield and Westchester counties are among the most generous in the world; please join us in helping our neighbors this holiday season. Our pets are part of our family and we would love for everyone who has a pet in our community to be able to do something if their pet is diagnosed with cancer. Riedel and Cody can’t do this without our help.

    Please consider making a donation to The Riedel and Cody Fund and The Veterinary Cancer Center will match a portion of every dollar donated. Please mark on your check or online donation that it is to be used for “The VCC Neighborhood”. Please mail your check to: Riedel and Cody Fund, 129 Glover Avenue, Norwalk, CT 06850. For your 100% tax deductible online donations, please visit www.riedelcody.org. We guarantee that at minimum 90% of your donation will be used to treat pets in need as administrative costs are generously covered by Riedel and Cody Fund co-founder Mark Tillinger. Thank you from the bottom of our hearts for helping and Happy Holidays, The doctors and staff of The Veterinary Cancer Center.

     

  3. Innogenics – Genomic Profiling for Pets: What information can it provide

    Innogenics is a specialty genomics reference laboratory that helps veterinarians and owners of pets with cancer by providing state-of-the-art molecular diagnostic analysis of tumor tissue at costs affordable to the pet owner. We provide a molecular profile of a dog’s tumor that details the cancer type and subtype and provides biomarker information useful in guiding decisions about current and novel therapeutic options.

    At its core, cancer is a genetic disease. Unregulated growth, inappropriate growth signals, blunted or absent response to “death” signals—all of these characteristics are regulated by genes.  For this reason, the promise of genomics in oncology is huge. The expectation of improved diagnostics, prognostics and therapeutics is shared by patients and oncologists alike.

    Gene expression analysis is widely used in human oncology.

    In the diagnostic phase of oncology, we certainly understand that an accurate diagnosis is necessary in order to prescribe the optimal therapy. A fantastic paper published in the Proceedings of the National Academy of Sciences (http://www.pnas.org/content/98/26/15149.short) reported that gene profiling was incredibly accurate in determining the type of cancer spanning 14 of the most common cancers. In addition, gene expression analysis showed that undifferentiated cancers based upon histology had gene expression patterns unlike their tissue of origin. The dramatically different gene expression accurately predicts the aggressive, abnormal biologic behavior of these tumors, similar to what most oncologists observe in the clinic.

    Gene expression patterns can also aid in the prognostic phase of oncology. Accurate prognostication is important, as it allows the clinician to identify patients who will likely do well or those who will do poorly. In a highly cited paper in Nature (http://www.nature.com/nature/journal/v415/n6871/full/415530a.html) the authors evaluate the gene expression pattern of 117 patients and they were able to conclude that “This gene expression profile will outperform all currently used clinical parameters in predicting disease outcome. Our findings provide a strategy to select patients who would benefit from adjuvant therapy.” The number of genes that need to be evaluated does not have to be large. In one paper (http://www.sciencedirect.com/science/article/pii/S1535610804001412) the authors prove that the ratio of only TWO genes was prognostic in breast cancer patients. As a clinician, the question of how will MY pet do is one I hear every day. Wouldn’t it be wonderful to be able to accurately answer these pet owners?

    When it comes to the cancer that is most treated in the veterinary world, lymphoma, can gene expression analysis help? The answer is a resounding yes. Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma in dogs and is very similar to DLBCL in humans. Gene expression analysis has proven useful in this disease for BOTH dogs and people (http://cancerres.aacrjournals.org/content/73/16/5029.abstract and http://www.nature.com/nature/journal/v403/n6769/full/403503a0.html). By routinely performing gene expression analysis on the lymphomas that we diagnose in dogs, it is possible, indeed expected, that therapy will be more effective. And at the end of the day, isn’t more effective therapy what we all want?